MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS)
Clinical trials for MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS) explained in plain language.
Never miss a new study
Get alerted when new MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS) trials appear
Sign up with your email to follow new studies for MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare mitochondrial disease: TTI-0102 enters phase 2 trial
Disease control Recruiting nowThis study tests an oral drug called TTI-0102 in 12 people aged 16–60 with MELAS, a rare genetic disorder that causes muscle weakness, lactic acid buildup, and stroke-like episodes. Participants receive either TTI-0102 or a placebo for 6 months to see if the drug improves walking…
Matched conditions: MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS)
Phase: PHASE2 • Sponsor: Thiogenesis Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 06:09 UTC
-
Hope for mitochondrial patients: new drug targets debilitating fatigue
Symptom relief Recruiting nowThis study tests an experimental medicine called sonlicromanol in 220 adults with a specific genetic form of mitochondrial disease (m.3243A>G mutation). The goal is to see if it reduces fatigue and improves physical abilities like balance and leg strength compared to a placebo. P…
Matched conditions: MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS)
Phase: PHASE3 • Sponsor: Khondrion BV • Aim: Symptom relief
Last updated May 26, 2026 06:17 UTC